Adriblastine and hypochloraemia Patient Reports February 10, 2012

Adriblastine Side Effects Report #4874838-0
Adriblastine side effect was reported by a Physician from FRANCE on Dec 19, 2005. Female patient, 58 years of age, was treated with Adriblastine. After drug was administered, patient experienced the following side effects: hypochloraemia, hypokalaemia, hyponatraemia, renal disorder. Adriblastine dosage: 40 MG (40 MG, QD), INTRAVENOUS. During the same period patient was treated with CISPLATIN, CYCLOPHOSPHAMIDE, ETOPOSIDE. Patient was hospitalized. Patient recovered.